Open comment allows key stakeholders to critically review and identify any errors or gaps in a draft guideline prior to its finalization and publication. It allows for greater transparency in the ASCO ...
All Conquer Cancer research grant applications are carefully reviewed and evaluated by an independent Grants Selection Committee (Committee) using consistent criteria across all applications for each ...
Conquer Cancer®, the ASCO Foundation, has a mission to accelerate breakthroughs in lifesaving research and empower people everywhere to conquer cancer. Through our Grants & Awards Program, we are ...
The 2026 ASCO Gastrointestinal Cancers Symposium is " Meeting the Moment: Cancer Research Shaping the Future of Patient Care " by presenting a comprehensive program that explores the latest ...
New targeted therapy plus chemotherapy combination may help shrink tumors in people with advanced colorectal cancer Who does this study affect? People who have metastatic colorectal cancer (mCRC) with ...
Launched in 2016, this award program honors extraordinary women leaders in oncology and role models who have excelled as mentors and have demonstrated outstanding commitment to the development of the ...
The American Society of Clinical Oncology (ASCO) is a medical professional oncology society committed to conquering cancer through research, education, prevention, and delivery of high-quality patient ...
Apply to be an ASCO International Cancer Corps Site! Applications are open for medical institutions in Asia Pacific LMICs now through April 14, 2026. Through its International Cancer Corps (ICC) ...
This section provides key information on oncology events organized by ASCO or other organizations throughout the world. To submit an event, please fill out this form. Content on ASCO's Calendar of ...
All Conquer Cancer research grant applications are carefully reviewed and evaluated by an independent Grants Selection Committee (Committee) using consistent criteria across all applications for each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results